2012
Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence?
Jauhar S, Guloksuz S, Andlauer O, Lydall G, Marques J, Mendonca L, Dumitrescu I, Roventa C, De Vriendt N, Van Zanten J, Riese F, Nwachukwu I, Nawka A, Psaras R, Masson N, Krishnadas R, Volpe U, European Federation of Psychiatric Trainees' Research Group. Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence? BMC Psychiatry 2012, 12: 27. PMID: 22463055, PMCID: PMC3337226, DOI: 10.1186/1471-244x-12-27.Peer-Reviewed Original ResearchConceptsSecond-generation antipsychoticsCognitive behavioral therapyUse of SGAsSecond-generation antipsychotic medicationsKnowledge of trialQuestionnaire-based studyAntipsychotic medicationAntipsychotic treatmentTreatment choicePatientsBehavioral therapyForms of psychotherapyOwn treatmentAntipsychoticsTreatmentPsychosisTrialsPsychiatry traineesEfficacyTrainees
2011
P03-79 - How do european psychiatry trainees prescribe when treating depression, and what influences decision-making? (Survey of the European Federation of Psychiatric Trainees Research Group)
Jauhar S, Guloksuz S, Marques J, Nawka A, Roventa C, Psaras R, Andlauer O, Lydall G, De Vriendt N, Mendonca L, Van Zanten J, Dumiterscu I, Nwachukwu I, Riese F, Group E. P03-79 - How do european psychiatry trainees prescribe when treating depression, and what influences decision-making? (Survey of the European Federation of Psychiatric Trainees Research Group). European Psychiatry 2011, 26: 1248. DOI: 10.1016/s0924-9338(11)72953-4.Peer-Reviewed Original ResearchSide effect profileClinical practiceChoice of antidepressantSevere depressive episodeAntidepressant medicationDepressive episodeTreatment choiceResponse rateAntidepressantsSimilar antidepressantsSubsequent guidelinesPatientsEvidence baseMinimum response rateGuideline suggestionsRecent evidenceMedicationsEuropean traineesPsychiatry traineesEfficacyLittle evidenceSample sizeTraineesFactorsRecent literature
2010
PW01-264 - How would European trainees treat bipolar disorder for their patients and themselves, and what influences decision-making?
Jauhar S, Lydall G, Riese F, Marques J, Bendix M, Andlauer O, Gerber S, De Vriendt N, Dumitrescu I, Nawka A, Guloksuz S, Mendonca L, Nwachukw I, Psaras R, Roventa C, Giacco D, Mufic A, Dobrzynska E, Nazaraliev A, Van Zanten J, Group E. PW01-264 - How would European trainees treat bipolar disorder for their patients and themselves, and what influences decision-making? European Psychiatry 2010, 25: 1596-1597. DOI: 10.1016/s0924-9338(10)71577-7.Peer-Reviewed Original ResearchP03-343 - Treatment choice in psychiatry? How would European trainees treat psychosis for their patients and themselves, and what influences decision-making?
Jauhar S, Guloksuz S, Marques J, Bendix M, Lydall G, Andlauer O, Gerber S, Roventa C, Van Zanten J, De Vriendt N, Nawka A, Nwachukw I, Dobrzynska E, Mufic A, Nazaraliev A, Dumitrescu I, Mendonca L, Riese F, Group E. P03-343 - Treatment choice in psychiatry? How would European trainees treat psychosis for their patients and themselves, and what influences decision-making? European Psychiatry 2010, 25: 958. DOI: 10.1016/s0924-9338(10)70949-4.Peer-Reviewed Original ResearchFirst-line therapySide effect profileTreatment choiceClinical practicePsychiatric clinical practiceEuropean traineesCATIE trialAntipsychotic medicationAntipsychoticsResponse ratePatientsEvidence baseMinimum response ratePsychosisRecent evidenceClozapineTherapyEfficacySample sizeTraineesPsychiatryMedicationsPrescribingFactorsResponders